CN Patent

CN114053258A — 在相伴他汀类疗法的对象中降低甘油三酯、没有增加ldl-c水平的组合物和方法

Assigned to Amarin Pharmaceuticals Ireland Ltd · Expires 2022-02-18 · 4y expired

What this patent protects

本发明涉及在相伴他汀类疗法的对象中降低甘油三酯、没有增加LDL‑C水平的组合物和方法。在各种实施方式中，本发明提供在需要其的对象中治疗和/或预防心血管相关疾病的组合物和/或方法。

USPTO Abstract

本发明涉及在相伴他汀类疗法的对象中降低甘油三酯、没有增加LDL‑C水平的组合物和方法。在各种实施方式中，本发明提供在需要其的对象中治疗和/或预防心血管相关疾病的组合物和/或方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN114053258A
Jurisdiction
CN
Classification
—
Expires
2022-02-18
Drug substance claim
No
Drug product claim
No
Assignee
Amarin Pharmaceuticals Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.